# Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

> **NCT00099086** · PHASE1 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 20 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Bicalutamide
- **DRUG:** docetaxel
- **DRUG:** GnRh analog
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT00099086
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-16
- **Primary completion:** 2011-01-20
- **Final completion:** 2023-12-13
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099086, "Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00099086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*